Anti-Aging: Can We Be Forever Young?

Metformin Research

Metformin, a drug traditionally used to treat type 2 diabetes, is gaining attention for its potential anti-aging benefits. Nir Barzilai, a professor at Albert Einstein College of Medicine, highlights studies showing that people with diabetes taking metformin live longer and have fewer health issues like cardiovascular disease and cognitive decline compared to those on other diabetes medications 1. Early research in mice also suggests metformin may reduce inflammation and boost antioxidants, potentially improving blood vessel health 2.

People on metformin who have diabetes have less cardiovascular disease, they have less cancers, they have less cognitive decline.

--- Nir Barzilai

These findings have sparked interest in whether non-diabetics might also benefit from metformin's longevity effects 2.

   

Scientific Debate

The scientific community is divided on metformin's role as an anti-aging drug. While Nir Barzilai is optimistic, citing studies where diabetics on metformin outlived non-diabetics, other research, like studies from Denmark, contradicts these findings, showing no longevity benefit for diabetics on metformin 2. Barzilai argues that more randomized control trials are needed to determine metformin's effects on aging in non-diabetics 2.

It's not about hope. It's about evidence.

--- Nir Barzilai

Despite the debate, metformin's status as an FDA-approved drug with a known safety profile makes it an attractive option for those exploring anti-aging therapies 2.